Japan's Big 3 Food Makers Q1 FY2027: Ajinomoto leads on AI materials
Companies compared · 3
Takeaway
Growth was broad, but earnings drivers determined who pulled ahead.
Japan's Big 3 Food Makers grew sales and operating profit in Q1 FY2027, but growth drivers diverged. Ajinomoto led revenue and margins on AI materials, Meiji net profit growth on pharmaceuticals, while Morinaga Milk cut its outlook.
Industry Overview
Combined sales for the three companies increased from a year earlier, and each posted higher operating profit. But the businesses driving earnings differed.
- Ajinomoto led sales growth. Revenue rose 13.2%, ahead of Meiji's 5.8% and Morinaga Milk's 2.4%. Electronic materials for AI and servers helped drive growth beyond food.
- Meiji accelerated profit growth. Operating profit climbed 27.7% and net profit rose 51.3%. Pharmaceuticals boosted earnings, offsetting the impact of high cocoa costs in food.
- Overseas business supported Morinaga Milk. Overseas sales jumped 25.4%, helped by higher whey protein market prices. Net profit, however, fell 3.4%.
- Profit margins also diverged sharply. Ajinomoto's 13.6% margin was well above Meiji's 7.8% and Morinaga Milk's 6.8%. Their mix of high-margin businesses drove the gap.
Sales Ranking
Ajinomoto ranked first in sales and posted the fastest growth among the three. Electronic materials for AI and servers added to the contribution from food.
Operating Profit Ranking
Ajinomoto led in operating profit. Meiji sharply increased earnings on pharmaceutical growth, while Morinaga Milk benefited from strong overseas business.
Operating Margin Ranking
Ajinomoto's margin was well above that of runner-up Meiji. Its mix of high-margin businesses, including electronic materials, is reflected in the gap.
Winner and Loser
Ajinomoto was the strongest overall performer. Sales reached ¥412.1 billion, up 13.2% from a year earlier. Operating profit rose 13.2% to ¥55.9 billion, while its 13.6% margin ranked first among the three. Electronic materials are becoming a second earnings engine alongside food.
Morinaga Milk faced the toughest quarter. Sales increased 2.4% to ¥147.1 billion, and operating profit rose 12.9% to ¥10 billion. But net profit declined 3.4%, and the company cut its full-year operating profit forecast to ¥34 billion. Higher raw-material and labor costs weighed on results.
Meiji posted sales of ¥289.4 billion, up 5.8%. Operating profit gained 27.7% to ¥22.7 billion, while net profit surged 51.3% to ¥15.3 billion. Pharmaceuticals lifted earnings, while high cocoa costs continued to pressure food. Different earnings engines shaped the companies' contrasting performances.
Winner
Ajinomoto
Laggard
Morinaga Milk
Strategic Moves to Watch
Sales of Ajinomoto's electronic materials for AI and servers were strong. The company forecasts full-year sales of ¥1.732 trillion and operating profit of ¥202 billion. It also raised its business profit outlook to ¥200 billion. Its growth in semiconductor-related materials is attracting attention alongside its well-known food business.
Pharmaceuticals drove Meiji's profit growth. In food, price increases and cost cuts are key to managing higher cocoa costs. Nutrition products such as SAVAS are a growth pillar for its nutrition business. The transfer of its China business also reflects a review of its portfolio.
Morinaga Milk benefited from whey protein at overseas subsidiary MILEI. Overseas sales growth of 25.4% supported higher operating profit, though it is unclear how long favorable market conditions will last. In Japan, the company faces pressure to shift its product mix toward items such as yogurt and protein products. Diversifying sources of growth will shape competitiveness.
Common Industry Risks
All three companies increased operating profit, but earnings could come under pressure if external conditions change. Raw-material costs and market prices are key areas to watch.
- Higher input costs. Meiji faces elevated cocoa prices, while Morinaga Milk is grappling with raw-material and labor costs. If customers resist price increases, profits could suffer.
- Market volatility. Rising whey protein prices have helped Morinaga Milk. A price reversal could slow growth in its overseas business.
- Reliance on growth markets. Strong electronic materials sales boosted Ajinomoto's results. A slowdown in semiconductor demand or AI investment could weaken growth momentum.
- Competition and quality requirements. Food makers must compete on price and product appeal, while pharmaceutical businesses must meet regulatory and quality-control requirements. Each company needs to balance growth investment with stable supply.
Ranking Shifts and Structural Trends
Ajinomoto ranked first in sales, operating profit and operating margin. It also led the group in year-on-year sales growth. Meiji, meanwhile, topped the group in net profit growth, with pharmaceuticals providing strength that is not apparent from sales scale alone.
The three companies' average operating margin was 9.4%, lifted by Ajinomoto's high margin. The comparison highlights the importance of high-return businesses such as electronic materials and pharmaceuticals, not just company size.
For Job Seekers and Career Changers
Food companies offer career paths beyond product development and sales. Semiconductor materials influence Ajinomoto's results, pharmaceuticals and nutrition matter at Meiji, and overseas dairy ingredients are important to Morinaga Milk.
When choosing a role, candidates should look beyond familiar food brands and consider each company's growth businesses. Overseas operations, research and development, raw-material procurement and quality control can also offer ways to apply specialist skills and broaden career options.
Year-on-Year Sales Growth
All three companies grew sales, but at different rates. Ajinomoto led on electronic materials, followed by Meiji and Morinaga Milk.
Year-on-Year Net Profit Growth
Meiji ranked first in net profit growth, driven by pharmaceuticals. Morinaga Milk increased operating profit but reported lower net profit.


